Home Exoskeleton that has enabled 125 million steps around the world now available in Central Virginia
Local

Exoskeleton that has enabled 125 million steps around the world now available in Central Virginia

Contributors

sheltering armsSheltering Arms and Sheltering Arms Institute are enhancing their rehabilitation programs by now offering the EksoNR™ robotic exoskeleton to help patients who have experienced neurological illness or injury learn to walk again.

Sheltering Arms Institute is the first inpatient rehabilitation hospital in Virginia to have an EksoNR clinical program. The Sheltering Arms outpatient location in Hanover has also acquired an EksoNR, providing hospital patients the opportunity to continue using the device on an outpatient basis as they progress in their recovery.

Each year, nearly 60 million people suffer from acquired brain injury, 15 million suffer a stroke, and as many as 500,000 experience a spinal cord injury (SCI). EksoNR is the first exoskeleton approved by the FDA for use with stroke and spinal cord injuries and the only exoskeleton with FDA approval for use with acquired brain injury patients.

“The EksoNR offers many unique benefits to our patients who are relearning to walk, as the device promotes early mobilization and can help improve gait speed and distance, which are critical factors for optimal recovery,” said Amber Walter, PT, DPT, NCS, clinical science manager at Sheltering Arms Institute.

The wearable robotic device offers patients upper trunk support and the opportunity to practice over-ground walking early on in their recovery process, retraining the brain and muscles how to properly walk again. This cutting-edge exoskeleton technology helps patients re-learn correct step patterns, weight shifting, and posture. Additionally, this device has shown promising results in walking speed, endurance, lower extremity strength, and functional mobility for persons with spinal cord injury.

Clinical evidence suggests that including EksoNR gait training in inpatient rehabilitation for stroke improves independence in functional mobility. Most patients take an average of 400 steps during first-time training in the device, including 48-year-old Calesta “CW” Saunders, Jr. who suffered an anterior spinal cord stroke in February.

“I woke up in the middle of the night with abdominal pain,” Saunders said. “Within 20 minutes, my legs were completely numb.” The spinal cord stroke left Saunders in a wheelchair, paralyzed from the waist down and unable to walk. Then he began using the EksoNR. It was the first time he took a normal step since the stroke. Within just three weeks, he was able to lift his legs, wiggle his toes, and crawl and has his sights set on walking again soon.

The purchase of the two EksoNR devices and support for ongoing staff training is funded by generous donors to Sheltering Arms Foundation.

Contributors

Contributors

Have a guest column, letter to the editor, story idea or a news tip? Email editor Chris Graham at [email protected]. Subscribe to AFP podcasts on Apple PodcastsSpotifyPandora and YouTube.